GPT Healthcare Q1 FY27 Earnings Call — Analysis (NSE: GPTHEALTH)
GPT Healthcare Q1FY27 PAT surges 66% YoY on ARPOB uplift from specialty mix shift and improving occupancies, while Raipur ramps up and Jamshedpur remains on track for Q4 commissioning.
The take
Q1FY27 Total income growth +18.2% ( +18.2% YoY ) . New guidance — Q4FY27 raipur hospital occupancy by fy… ~30% . New story: Specialty mix shift driving ARPOB .
Results
Revenue from operations ₹126.2 Cr (+18.2% total income YoY); EBITDA ₹26.2 Cr (margin 20.4%); PAT ₹12.7 Cr (+66% YoY); network ARPOB ₹42,350; mature hospital occupancy (ex-Raipur) 58.07%.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from operations | ₹126.2 Cr | none · Q1FY27 | |
| Total income growth | +18.2% | +18.2% | yoy · Q1FY27 |
| EBITDA | ₹26.2 Cr | none · Q1FY27 | |
| EBITDA margin | 20.4% | none · Q1FY27 | |
| PAT | ₹12.7 Cr | +66% | yoy · Q1FY27 |
| PAT margin | 9.9% | none · Q1FY27 | |
| Network ARPOB | ₹42,350 | none · Q1FY27 | |
| Network occupancy | 45.5% | none · Q1FY27 | |
| Mature hospital occupancy (ex-Raipur) | 58.07% | none · Q1FY27 |
Guidance
FY27 EBITDA margin guided to ~21% (₹110–115 Cr) and Raipur exit occupancy targeted at ~30%.
What management committed to
- We expect to close the year at around 30% occupancy at Raipur. — ~30%, Q4FY27
- We expect to close the year at around 21% EBITDA margins compared to the 19% of last year, translating to somewhere around ₹110 crores or ₹115 crores. — ~21% and ₹110–115 Cr, FY27
- The 155-bed Jamshedpur hospital is expected to be commissioned during Q4 FY27, likely late in the quarter; if approvals delay, it may be pushed to the beginning of next year. — Q4 FY27, Q4FY27
- Jamshedpur hospital initial ARPOB should be around the ₹38,000 to ₹40,000 mark, catching up to Kolkata levels of ₹42,000–43,000 over time. — ₹38,000–40,000, initial ramp-up phase
- We expect Jamshedpur hospital to break even in around 24 months, though historically we have broken even within 12 months in Dumdum and Howrah, and expect Raipur around the 20-month mark. — ~24 months, 24 months from commissioning
- We are evaluating opportunities for our seventh hospital, which will increase our network capacity to over 1,000 beds in the next 2 years. — >1,000 beds, FY28
- Agartala hospital international patient inflows should get back to pre-disruption levels in the next 6 months. — pre-disruption levels, Q3FY27
- We expect Dumdum hospital occupancy to reach optimum levels this year itself; last year we touched 70% in a couple of quarters, and we expect that to become normal by Q3 of this year. — ~70%, Q3FY27
Key themes
Specialty mix shift and ARPOB growth
How the narrative shifted
- Specialty mix shift driving ARPOB: Management attributes ARPOB growth entirely to higher-acuity tertiary/quaternary case mix (robotic surgeries, transplants, oncology) rather than tariff hikes, positioning it as a structural earnings lever.
- New hospital ramp-up (Raipur & Jamshedpur): Raipur occupancy tripled YoY to 17% and is on track for 30% exit; Jamshedpur commissioning stays on schedule with clear ARPOB and breakeven targets, underscoring a replicable expansion model.
- Asset-light expansion model: Raipur and Jamshedpur are developed on long-term rental models, reducing upfront capital intensity; management remains flexible but sees the model as successful in certain locations.
- International patient inflow recovery: Bangladesh inflows have improved but remain below pre-disruption levels; policy changes (visa requirements linking to target hospitals) are aiding a gradual recovery, with full normalization expected in 6 months.
- Long-term return targets: Management reiterates a 25% ROE/ROCE aspiration, driven by occupancy gains, specialty mix, and asset-light greenfields, signaling confidence in capital efficiency over the cycle.
- Market education in underpenetrated regions: Howrah and Raipur require investment in patient trust and brand awareness as first-mover corporate hospitals; progress is steady with 31% revenue growth in Howrah.
Operational commentary
- Raipur hospital completed first liver transplant, attained NABH accreditation in 13 months, occupancy improved to 17% (vs 7% YoY), loss steady at ₹3 Cr; target exit occupancy 30%.
- 155-bed Jamshedpur greenfield on schedule for late Q4 FY27 commissioning; asset-light model with rental ~mid-30s; breakeven targeted in ~24 months but management leans on historical benchmarks of 12–20 months.
- Salt Lake flagship completed >800 robotic surgeries cumulatively, received DRNB accreditation in medical gastroenterology, occupancy 62% (vs 60% YoY), ARPOB ₹45,300.
- Dumdum hospital delivered highest network occupancy at 65% (vs 60% YoY); newly started cardiac surgeries achieved ~200 procedures in 5 months; renal transplant tally >700.
- Agartala ARPOB surged 70% to ₹41,573 driven by high-end tertiary mix; occupancy dip due to tribal elections and deliberate reduction in length of stay; international patient inflows from Bangladesh improving but below pre-disruption levels; July occupancy recovered to 51%.
- Howrah revenue grew 31% YoY with occupancy up 16% (YoY); MAKO robotic knee program strengthening orthopaedic franchise; focus extending to nephrology and cardiology.
- Overall ARPOB increase entirely case-mix driven; annual tariff revision slated for October (inflation-linked); length of stay reduced across hospitals.
- Payer mix remains strong with ~90% cash and insurance revenues; government patient contribution minimal and not being pursued aggressively due to lower ARPOB and payment delays.
- Doctor attrition low (single-digit in Kolkata, ~10% in Agartala/Raipur); nursing college in Agartala supports nurse pipeline.
- Evaluating 7th hospital in Tier-1/2 cities of Eastern India (Cuttack, Ranchi, Patna, Banaras, Prayagraj) via greenfield or acquisition; management not fixated on asset-light model alone.
- Network capacity target >1,000 beds over the next two years with the 7th hospital addition.
Analyst Q&A
Q. What caused the dip in Agartala occupancy?
Tribal elections in Tripura in May restricted patient movement for about a month, and we consciously reduced average length of stay from 3.38 to 3 days. Despite lower occupancy, ARPOB improved 70% and July occupancy reached 51%.
Q. Can you provide medium-term guidance on occupancy and mature hospital revenue growth?
We'll request MUFG to get back to you on that.
Q. Is the ARPOB increase in Agartala and Howrah from high-end treatments or price hikes?
No tariff increase taken; the increase is purely from incremental change in case mix towards high-end tertiary care like cardiology, oncology, neurosciences. We hope this will continue.
Q. What is the debt position and Jamshedpur capex?
Debt unchanged from last year; Jamshedpur will draw down debt of ~₹25 Cr during this fiscal.
Q. What is the expected ARPOB and breakeven timeline for Jamshedpur?
Initial ARPOB ₹38,000–40,000, catching up to Kolkata levels of ₹42,000–43,000. Historically we broke even in 12–24 months; we are confident of similar timelines.
Research and educational content only. Not investment advice.